Rami Komrokji, MD

Articles by Rami Komrokji, MD

Chadi Nabhan, MD, MBA, FACPThe HemOnc Pulse | July 26, 2024
Rami Komrokji, MD, describes incorporation of molecular data, tailoring treatment by disease risk, and new therapies in MDS.
Listen Now
Chadi Nabhan, MD, MBA, FACPMyelodysplastic Syndromes | May 13, 2024
The panel mainly focused on how to define and classify MDS and CHIP, as well as how to treat low- and high-risk MDS.
Chadi Nabhan, MD, MBA, FACPThe HemOnc Pulse Live | May 8, 2024
Live in Chicago, this podcast episode features a panel discussion on unanswered questions in AML.
Rami Komrokji, MDMyelodysplastic Syndromes | February 21, 2024
Rami Komrokji, MD, discussed the impact of luspatercept on the genomic landscape in patients with lower-risk MDS.
Rami Komrokji, MDAcute Myeloid Leukemia | September 12, 2023
The crew talk about AML and MDS in this episode of The HemOnc Pulse.
Rami Komrokji, MDVideo Insights | September 13, 2023
Dr. Komrokji speaks about what might follow the recent FDA approval of luspatercept for certain patients with MDS.